Piperaquine | List of Frontiers open access articles

Brief Research Report

Published on 30 Apr 2024

Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay

in Clinical and Diagnostic Microbiology and Immunology

Annabelle Walz
Sibylle Sax
Christian Scheurer
Balint Tamasi
Pascal Mäser
Sergio Wittlin

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1396786

2,634 views
1 citation

Case Report

Published on 17 Jan 2022

Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria

in Infectious Diseases: Pathogenesis and Therapy

Marion Louvois
Loïc Simon
Christelle Pomares
Pierre-Yves Jeandel
Elisa Demonchy
Michel Carles
Pascal Delaunay
Johan Courjon

Frontiers in Medicine

doi 10.3389/fmed.2021.756050

6,073 views
2 citations

Original Research

Published on 16 Jun 2021

Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite Plasmodium berghei

in Parasite and Host

Mie Ikeda
Makoto Hirai
Shin-Ichiro Tachibana
Toshiyuki Mori
Toshihiro Mita

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.672691

3,750 views
6 citations

Original Research

Published on 05 Aug 2022

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

in Infectious Diseases: Epidemiology and Prevention

Qian Huang
Wen-Jie Xu
Xiao-Xiao Wang
Xuan Zhang
Ke-Nu Pan
Jia-Qi Zhang
Hua-Liang Chen
Wei Ruan
Li-Nong Yao

Frontiers in Public Health

doi 10.3389/fpubh.2022.871374

3,854 views
4 citations

Original Research

Published on 12 May 2022

Development and Validation of a Novel Diagnostic Model for Childhood Autism Spectrum Disorder Based on Ferroptosis-Related Genes

in Autism

Xiaolu Wu
Ran Li
Qin Hong
Xia Chi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.886055

4,688 views
15 citations

Original Research

Published on 15 Mar 2021

The Knockout for G Protein-Coupled Receptor-Like PfSR25 Increases the Susceptibility of Malaria Parasites to the Antimalarials Lumefantrine and Piperaquine but Not to Medicine for Malaria Venture Compounds

in Antimicrobials, Resistance and Chemotherapy

Benedito M. Santos
Bárbara K. M. Dias
Myna Nakabashi
Celia R. S. Garcia

Frontiers in Microbiology

doi 10.3389/fmicb.2021.638869

5,245 views
12 citations

Original Research

Published on 14 Oct 2022

In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers

in Parasite and Host

Wei Zhao
Xinxin Li
Qi Yang
Longcan Zhou
Mengxi Duan
Maohua Pan
Yucheng Qin
Xiaosong Li
Xun Wang
Weilin Zeng

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.1015957

7,702 views
11 citations

Articles

Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay

Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria

Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite Plasmodium berghei

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

Development and Validation of a Novel Diagnostic Model for Childhood Autism Spectrum Disorder Based on Ferroptosis-Related Genes

The Knockout for G Protein-Coupled Receptor-Like PfSR25 Increases the Susceptibility of Malaria Parasites to the Antimalarials Lumefantrine and Piperaquine but Not to Medicine for Malaria Venture Compounds

In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers